Services Export of Plegridy Injection

Export of Plegridy Injection

Derek Clarke is an established exporter of PLEGRIDY Injection to healthcare professionals around the world. 

PLEGRIDY injection (peginterferon beta-1a, Biogen Idec) is a subcutaneous injectable therapy for relapsing forms of multiple sclerosis (RMS). PLEGRIDY injection is the only pegylated interferon approved for the treatment of RMS and is administered every two weeks.
MS is an auto-immune disease of the central nervous system, whereby the immune system attacks nerve cells and causes scars or lesions within the CNS. Common symptoms of MS include:



  • Fatigue
  • Optic Neuritis (Loss of vision in one eye, blurred or double vision)
  • Weakness of limbs
  • Reduced co-ordination
  • Balance problems
  • Numbness
  • Pins & needles

Derek Clarke, with more than 30 years as experience as an exporter of both branded and generics medicines, is able to source and supply products, often unavailable through other sources, quickly and efficiently.

For more information on the export of PLEGRIDY injection, please contact us on

+44 (0) 208 952 2061